Mark Smith
Directeur/Membre du Conseil chez Freya Biosciences ApS
Fortune : 142 092 $ au 30/04/2024
Postes actifs de Mark Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Freya Biosciences ApS
 Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Mark Smith
Anciens postes connus de Mark Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur/Membre du Conseil | 01/09/2017 | 15/05/2023 |
| Directeur Général | 01/09/2017 | 15/05/2023 | |
| Fondateur | 01/09/2017 | 15/05/2023 | |
The Microbiome Health Research Institute, Inc.
 The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Directeur/Membre du Conseil | 01/01/2012 | 01/07/2016 |
| Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/07/2016 | |
| Fondateur | 01/01/2012 | 01/07/2016 | |
| President | 01/01/2012 | 01/07/2016 |
Formation de Mark Smith
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Danemark | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Commercial Services | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
The Microbiome Health Research Institute, Inc.
The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Commercial Services |
Freya Biosciences ApS
Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Mark Smith
- Expérience
